PharmaBoardroom

Impact of COVID-19 on US Clinical Studies Conducted by…

Writing in the June edition of DIA’s Global Forum magazine, representatives of Japanese pharmaceutical companies with US operations outline how the…

Georg Schroeckenfuchs – President MEA and Head Gulf &…

Georg Schroeckenfuchs, Novartis’ president MEA and head of its Gulf and Saudi Country Group, explains how the company’s objectives are aligned…

Opportunities for the Life Science Industry in Australia…

Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the…

Haitham Habashi – General Manager, Merck KSA

Haitham Habashi, general manager for Merck Saudi Arabia, outlines his affiliate’s approach to the big reforms shaping the country’s healthcare…

Australia: Growing Clinical Trials Even in Pandemic’s Wake

In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of New South Wales, Medicine, St.…

Susanne Caspar – CEO, Linnea

Susanne Caspar, CEO at Swiss natural API producer Linnea, talks about her first few months in the company, the pharmaceutical industry’s growing…

Georg Boonen – CEO, Max Zeller

Georg Boonen, CEO of Switzerland’s leading phytopharmaceutical player Max Zeller, discusses the company’s expanded market position at home and…

Japan PMDA New Drug Approvals 2020

Following on from our recent compilations of 2020 new drug approvals in the USA, China, and Switzerland, see below for the Japanese PMDA's new drug…

Ans Heirman – AVP Managing Director, MSD Switzerland

Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and global functions across four sites in…

Barış Erdoğan – CEO, Clinerion

Clinerion, a leader in real-world data solutions, is helping bring medical data informatics to the life sciences industry. CEO Barış Erdoğan…

Filip Standaert – Managing Director Nordics, Johnson &…

Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe, how the affiliate responded to the…

Christian Probst – General Manager, GSK Norway

Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of bringing clinical trials back to…

Tagged with ALS